RIETE注册研究中接受与未接受遗传性易栓症检测的静脉血栓栓塞症患者的特征与结局
基于RIETE前瞻性注册研究103 818例静脉血栓栓塞症(VTE)患者,21 089例(20.3%)接受遗传性易栓症(IT)检测、8 422例(8.1%)阳性、82 729例(79.7%)未检测。IT检测在轻微诱因VTE中更常见、在手术或活动性癌症等重大诱因中较少见,抗凝选择不因检测结果而异;未检测者复发、大出血、死亡及癌症相关死亡率更高。
要点
- 103 818例VTE患者中20.3%接受IT检测,8.1%阳性,79.7%未检测。
- 未检测患者在各VTE类别中VTE复发、大出血、死亡及癌症相关死亡率均更高。
- 停药后,手术诱因VTE的IT阴性者复发率较低;无诱因VTE尤其IT阳性者复发率高。
核心结论
- IT检测在VTE管理中的作用复杂,支持考虑VTE危险因素与合并症的个体化治疗策略。
研究设计与样本
- 分析大型前瞻性RIETE注册研究数据,比较接受与未接受IT检测的VTE患者的危险因素、管理及抗凝期间和停药后结局。
- 共纳入103 818例患者,21 089例(20.3%)接受IT检测,8 422例(8.1%)检测阳性,82 729例(79.7%)未检测。
- 试验注册号NCT02832245。
主要发现
- IT检测在轻微危险因素所致VTE患者中更频繁,在手术或活动性癌症等重大危险因素患者中较少见。
- 抗凝治疗选择不因IT检测结果而不同。
- 未检测患者在所有VTE类别中结局更差,VTE复发、大出血、死亡率及癌症相关死亡率更高。
- 停药后,手术诱因VTE的IT阴性患者复发率较低;制动相关VTE及雌激素相关VTE中IT阴性与IT阳性患者复发率无显著差异。
- 妊娠或产后相关VTE的IT阴性患者复发率显著较低;无诱因VTE患者尤其IT阳性者治疗后复发率高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inherited thrombophilia (IT) workup is commonly pursued in patients with venous thromboembolism (VTE). Recent American Society of Hematology guidelines recommend a selective approach to IT testing, nevertheless, evidence on whether thrombophilia testing can actually improve patient-important outcomes through tailored management is limited. Data from the large, prospective Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry were analyzed to compare VTE risk factors, management, and outcomes between patients who were tested for IT and untested patients, during anticoagulant treatment and after its discontinuation. Among 103 818 patients enrolled in RIETE, 21 089 (20.3%) were tested for IT, 8422 (8.1%) tested positive, and 82 729 (79.7%) were not tested. IT testing was more frequent in patients with VTE provoked by minor risk factors and less common in those with major risk factors such as surgery or active cancer. Choices of anticoagulant treatment did not differ based on IT testing results. Untested patients exhibited inferior outcomes across all VTE categories, with higher rates of VTE recurrence, major bleeding, mortality, and notably, cancer-related mortality. After treatment discontinuation, IT-negative patients with surgically provoked VTE showed lower recurrence rates. For immobilization-related VTE as well as in estrogen-related VTE, no significant differences in recurrence rates were observed between IT-negative and IT-positive patients. However, IT-negative patients with pregnancy or postpartum-related VTE had significantly lower recurrence rates. Patients with unprovoked VTE, particularly those testing positive for IT, had high recurrence rates after treatment. These findings underscore the complex role of IT testing in managing VTE, supporting personalized treatment strategies that consider VTE risk factors and comorbidities. The trial was registered at www.clinicaltrials.gov as #NCT02832245.
引用
- Cohen O, Waldman Radinsky L, Kenet G, et al. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia. Blood Adv. 2024. PMID: 38669351. doi:10.1182/bloodadvances.2024012611
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。